Bizacumen Inc., Nov 2009, Pages: 353
Players in French
Market for Automated Identification and Susceptibility Systems
- 2000
Table 53: Automated and Rapid Microbiological Tests Market by
End- Use Segment in France
Global Industry Analysts, Inc., Oct 2011, Pages: 660
Rapid
Tests, and Other Automated & Rapid Microbiological Tests)
and Non-Clinical Applications for 2003, 2010 & 2017
(includes corresponding Graph/Chart) 178
14a. FRANCE 179
A.Market Analysis 179
Global Industry Analysts, Inc., April 2011, Pages: 539
Table 19: European Recent Past, Current and Future Analysis
for Clinical Diagnostics Automation by Geographic Region -
France, Germany, Italy, UK, Spain, and Rest of Europe
Markets Independently
Venture Planning Group, June 2011, Pages: 1900
symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.
Geographic Coverage
- France
Venture Planning Group, April 2010, Pages: 420
. Worldwide Market Overview
1. Business Environment
2. Market Structure
3. Market Size and Growth
France
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major
Venture Planning Group, Feb 2012, Pages: 800
preparation devices, controls, calibrators, and innovative IT applications.
Geographic Coverage
- France
- Germany
- Italy
- Japan
- Spain
- UK
- USA
This comprehensive seven-country report is designed
Venture Planning Group, Nov 2011, Pages: 800
Blood Transfusion/Freezing
D. Worldwide Market Overview
1. Business Environment
2. Market Structure
3. Market Size and Growth
France
A. Executive Summary
B. Business Environment
C. Market Structure
D
ICON Group International, Jan 2011, Pages: 329
at the category level. Countries that typically have ample data at the aggregate level that meet the efficiency criteria include the United States, the United Kingdom and in some cases France and Germany. Latent
ICON Group International, Jan 2011, Pages: 200
the latent demand for automated and rapid microbiological tests on a worldwide basis, I used a multi-stage approach. Before applying the approach, one needs a basic theory from which such estimates are created
ICON Group International, Jan 2011, Pages: 72
at the aggregate level that meet the efficiency criteria include the United States, the United Kingdom and in some cases France and Germany. Latent demand is therefore estimated using data collected for relatively
ICON Group International, Jan 2011, Pages: 58
, the United Kingdom and in some cases France and Germany. Latent demand is therefore estimated using data collected for relatively efficient markets from independent data sources (e.g. Euromonitor, Mintel, Thomson
ICON Group International, Jan 2011, Pages: 38
and in some cases France and Germany. Latent demand is therefore estimated using data collected for relatively efficient markets from independent data sources (e.g. Euromonitor, Mintel, Thomson Financial
ICON Group International, Jan 2011, Pages: 35
include the United States, the United Kingdom and in some cases France and Germany. Latent demand is therefore estimated using data collected for relatively efficient markets from independent data sources
ICON Group International, Jan 2011, Pages: 37
. Countries that typically have ample data at the aggregate level that meet the efficiency criteria include the United States, the United Kingdom and in some cases France and Germany. Latent demand
ICON Group International, Jan 2011, Pages: 35
, the United Kingdom and in some cases France and Germany. Latent demand is therefore estimated using data collected for relatively efficient markets from independent data sources (e.g. Euromonitor, Mintel, Thomson
Venture Planning Group, June 2011, Pages: 1050
tasks for diagnostic companies during the next ten years.
Geographic Coverage
- France
- Germany
- Italy
- Japan
- Spain
- UK
- USA
Worldwide Market Overview
- Laboratories performing DNA sequencing
Global Industry Analysts, Inc., Aug 2010, Pages: 589
Graph/Chart)
Product Launches
Strategic Corporate Development
B.Market Analytics
Table 38: European Recent Past, Current & Future Analysis
for Immunoassay Systems by Geographic Region - France
Venture Planning Group, Feb 2010, Pages: 1050
. Flow Cytometry
I. REIMBURSEMENT ISSUES
J. WORLDWIDE MARKET OVERVIEW
1. Business Environment
2. Market Structure
3. Market Size and Growth
III. FRANCE
A. EXECUTIVE SUMMARY
B. BUSINESS ENVIRONMENT
C
